• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星(DL - 8280)治疗各种感染的临床经验。

Clinical experience with ofloxacin (DL-8280) in the therapy of various infections.

作者信息

Cristiano P, Iovene M R, Morelli G, Mandia L, Paradisi F, Altucci P

机构信息

Institute of Internal Medicine, 1st Medical School, Naples University, Italy.

出版信息

J Chemother. 1989 Apr;1(2):107-9. doi: 10.1080/1120009x.1989.11738875.

DOI:10.1080/1120009x.1989.11738875
PMID:2732779
Abstract

Thirty-four hospitalized patients with various infections: 19 with typhoid fever, 4 with gastroenteritis, 7 with lower respiratory tract infections, 2 with biliary tract infections, 1 with brucellosis and 1 with infection of necrotic ulceration of the feet, were treated with ofloxacin at a daily dosage ranging between 600 and 900 mg orally. Thirty-one of 34 patients (91.18%) completely recovered and pathogens were eradicated. In 2 patients, both with respiratory tract infections, the treatment failed and in one patient, affected by infection of necrotic ulcerations of the feet, improvement was registered. No side effects were recorded. Ofloxacin can be considered a safe and effective antimicrobial agent in the therapy of these infections.

摘要

34例住院的各种感染患者:19例患伤寒热,4例患肠胃炎,7例患下呼吸道感染,2例患胆道感染,1例患布鲁氏菌病,1例患足部坏死性溃疡感染,口服氧氟沙星,日剂量在600至900毫克之间。34例患者中有31例(91.18%)完全康复,病原体被根除。2例均为呼吸道感染的患者治疗失败,1例足部坏死性溃疡感染患者病情有改善。未记录到副作用。氧氟沙星可被认为是治疗这些感染的一种安全有效的抗菌药物。

相似文献

1
Clinical experience with ofloxacin (DL-8280) in the therapy of various infections.氧氟沙星(DL - 8280)治疗各种感染的临床经验。
J Chemother. 1989 Apr;1(2):107-9. doi: 10.1080/1120009x.1989.11738875.
2
Clinical experience with ofloxacin (DL 8280) in the therapy of various infections: preliminary report.
Infection. 1986;14 Suppl 4:S307-8. doi: 10.1007/BF01661302.
3
Clinical experience with parenteral and oral ofloxacin in severe infections.氧氟沙星肠胃外和口服给药治疗严重感染的临床经验。
Scand J Infect Dis Suppl. 1990;68:64-9.
4
Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.口服氧氟沙星用于治疗对口服抗菌药物耐药的细菌引起的感染。
Diagn Microbiol Infect Dis. 1992 Jul;15(5):435-9. doi: 10.1016/0732-8893(92)90085-8.
5
Sequential therapy with i.v. and oral ofloxacin in lower respiratory tract infections: a comparative study.静脉注射和口服氧氟沙星序贯治疗下呼吸道感染:一项对比研究。
Infection. 1991;19 Suppl 7:S380-3. doi: 10.1007/BF01715832.
6
[Clinical study of Chinese ofloxacin].[国产氧氟沙星的临床研究]
Zhonghua Yi Xue Za Zhi. 1993 Apr;73(4):238-41, 255-6.
7
Brodimoprim: therapeutic efficacy and safety in the treatment of bacterial infections.溴莫普明:治疗细菌感染的疗效与安全性
J Chemother. 1993 Dec;5(6):507-11.
8
A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections.一项比较低剂量环丙沙星和氧氟沙星治疗下呼吸道感染的随机研究。
Infection. 1994 Jan-Feb;22(1):62-4. doi: 10.1007/BF01780772.
9
Oral ofloxacin therapy of infections due to multiply-resistant bacteria.口服氧氟沙星治疗多重耐药菌引起的感染。
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):435-41. doi: 10.1016/0732-8893(91)90070-v.
10
[Effectiveness of ofloxacin in the treatment of bacterial infections of the respiratory tract].
Pol Tyg Lek. 1988 Dec 5;43(49):1580-2.